Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 Illness: A Phase II B Open Labelled Randomized Controlled Trial.
COVID-19
Ivermectin
Survival
Symptom progression
Journal
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
ISSN: 0971-4502
Titre abrégé: Indian J Hematol Blood Transfus
Pays: India
ID NLM: 9425818
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
08
02
2022
accepted:
26
04
2022
pubmed:
8
6
2022
medline:
8
6
2022
entrez:
7
6
2022
Statut:
ppublish
Résumé
Repurposed drugs may reduce morbidity and mortality in patients with hematological disorders who develop COVID-19 illness. 112 patients with predominantly hematological illnesses were randomized to receive standard of care, ivermectin 12 mg [Iv 12] or 24 mg [Iv24] for asymptomatic, mild, or moderate COVID 19 illness. Serial respiratory samples for rRT-PCR samples were sent on Day 3, 5 and 7. rRT-PCR negativity and ≥ 2 log
Identifiants
pubmed: 35669353
doi: 10.1007/s12288-022-01546-w
pii: 1546
pmc: PMC9135993
doi:
Types de publication
Journal Article
Langues
eng
Pagination
615-622Informations de copyright
© The Author(s), under exclusive licence to Indian Society of Hematology and Blood Transfusion 2022.
Déclaration de conflit d'intérêts
Conflict of interestNo conflicts of interest to declare for any of the authors.
Références
BMJ. 2021 Apr 26;373:n949
pubmed: 33903131
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
EClinicalMedicine. 2021 Feb;32:100720
pubmed: 33495752
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
JAMA. 2021 Apr 13;325(14):1426-1435
pubmed: 33662102
Viruses. 2021 Mar 08;13(3):
pubmed: 33800528
Transfus Apher Sci. 2021 Jun;60(3):103075
pubmed: 33574010
Lancet. 2020 Jun 20;395(10241):1919-1926
pubmed: 32473682
Viruses. 2021 May 26;13(6):
pubmed: 34073401
Blood. 2020 Nov 12;136(20):2290-2295
pubmed: 32959052
Ann Hematol. 2020 Dec;99(12):2953-2956
pubmed: 32583087
J Med Virol. 2021 Oct;93(10):5833-5838
pubmed: 34076901
BMC Infect Dis. 2021 May 4;21(1):411
pubmed: 33947344
Int J Infect Dis. 2021 Feb;103:214-216
pubmed: 33278625
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Exp Hematol Oncol. 2020 Aug 25;9:21
pubmed: 32864192
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
Clin Ther. 2021 Jun;43(6):1007-1019
pubmed: 34052007
J Int Med Res. 2021 May;49(5):3000605211013550
pubmed: 33983065
Lancet Haematol. 2020 Oct;7(10):e737-e745
pubmed: 32798473
Am J Respir Crit Care Med. 2020 May 1;201(9):1150-1152
pubmed: 32200654